Hørsholm, Denmark

Dorthe Vang

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Hoffmann-La Roche Inc.. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Dorthe Vang

Introduction

Dorthe Vang is a prominent inventor based in Horsholm, Denmark. She has made significant strides in the field of biotechnology, particularly in the development of therapeutic solutions for neurological disorders. Her work exemplifies the intersection of innovation and healthcare, showcasing the potential of scientific research to improve patient outcomes.

Latest Patents

Dorthe Vang holds a patent for an "Antisense oligonucleotide for targeting progranulin." This invention relates to oligonucleotides that alter the splicing pattern of progranulin in cells, offering a novel approach to treating neurological disorders. The implications of her research could pave the way for new therapeutic strategies in managing these complex conditions.

Career Highlights

Dorthe Vang is currently associated with Hoffmann-La Roche Inc., a leading global healthcare company. Her role at the company allows her to collaborate with other experts in the field and contribute to groundbreaking research. With her innovative mindset, she continues to push the boundaries of what is possible in biotechnology.

Collaborations

Dorthe has worked alongside notable colleagues such as Ravi Jagasia and Lars Jonson. These collaborations have enriched her research and expanded the impact of her inventions in the scientific community.

Conclusion

Dorthe Vang's contributions to the field of biotechnology are noteworthy, particularly her patent on antisense oligonucleotides. Her work not only highlights her innovative spirit but also underscores the importance of collaboration in advancing scientific research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…